- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07749222
Pulmonary Function, Respiratory Muscle Strength, Lung Age, Balance, And Quality Of Life In Paralympic Athletes
Investigation Of Pulmonary Function, Respiratory Muscle Strength, Lung Age, Balance, And Quality Of Life In Paralympic Athletes: A Cross-Sectional Study
Paralympic athletes actively participate in many sports despite their physical limitations and continue to develop both individually and athletically. Assessing the physical and functional capacities of these athletes is important in terms of performance and health. This study aimed to examine the relationships between respiratory function, respiratory muscle strength, lung age, balance, and quality of life in Paralympic athletes. Additionally, it was evaluated whether there were significant differences in these parameters according to disability type and gender.
The study included 24 Paralympic athletes from the disciplines of athletics, swimming, archery, and wheelchair basketball. Participants had various orthopeadic and neurological disability types, including cerebral palsy, lower extremity amputation, spinal cord injuries (C5-T6 and T7 and below), hypotonia, poliomyelitis, spina bifida, brachial plexus injury, and short stature. Respiratory function was assessed using forced vital capacity (FVC), forced expiratory volume in one second (FEV₁), FEV₁/FVC ratio, peak expiratory flow (PEF), and forced expiratory flow (FEF25-75%); respiratory muscle strength was assessed using maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP). Lung age was calculated based on FEV₁ values, balance was measured using the Modified Functional Reach Test, and quality of life was determined using the Short Form (SF-36) questionnaire. Significant correlations were found between parameters. Based on the study results, supporting respiratory muscle strength in Paralympic athletes may be an important goal in rehabilitation and training programs to support respiratory function, lung age, and quality of life parameters.
Aperçu de l'étude
Statut
Les conditions
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
-
Istanbul, Turquie (Türkiye)
- İstanbul Okçular Vakfı
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Being between 18-50 years of age
- Being registered with any of the sports federations in Turkey and being a licensed paralympic athlete for at least 1 year (
- Having a lower extremity or upper extremity amputation or having permanent injuries as determined by the International Paralympic Committee
Exclusion Criteria:
- Lack of consent to participate in the study.
- Having undergone surgery within the last 6 months.
- Having had a respiratory tract infection within the three weeks prior to the evaluations
- FEV1/FVC < 0.7
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Forced expiratory volume in the first second (FEV1) (L)
Délai: 4 months
|
Pulmonary function (Forced expiratory volume in the first second FEV1)) was evaluated with a portable spirometer, COSMED Pony FX® (COSMED S.r.l., Italy) and measurements were performed according to European Respiratory Society standards. Considering that dizziness may occur during forced expiration, measurements were made while individuals were in a sitting position. While participants were sitting in a comfortable position in a chair with a backrest, nose clip was attached and they were asked to bite the mouth teeth and close their lips in a way that did not allow air to escape. The tests were performed at least 3 times by the participants and care was taken to ensure that the expiration time was at least 6 seconds and the plateau time was 1 second. Due to the device software that records all three data, it saved the average of the two best data and processed it as a value. |
4 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Forced vital capacity (FVC) (L)
Délai: 4 months
|
Pulmonary function ((Forced vital capacity (FVC )) was evaluated with a portable spirometer.
|
4 months
|
|
FEV1 / FVC (%)
Délai: 4 months
|
Pulmonary function (FEV1 / FVC) was evaluated with a spirometer.
|
4 months
|
|
Peak flow rate (PEF) (L/s)
Délai: 4 months
|
Pulmonary function (Peak flow rate (PEF)) was evaluated with a spirometer.
|
4 months
|
|
Flow rate 25-75% of forced expiratory volume (FEF 25-75%) (L/s)
Délai: 4 months
|
Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%)) was evaluated with a spirometer.
|
4 months
|
|
Maximal expiratory pressure (MEP) (L)
Délai: 4 months
|
The MEP which shows respiratory muscle strength was evaluated using a portable mouth pressure measuring device based on European Respiratory Society criteria.
|
4 months
|
|
Maximal inspiratory pressure (MIP) (L)
Délai: 4 months
|
The MIP which shows respiratory muscle strength was evaluated using a portable mouth pressure measuring device based on European Respiratory Society criteria.
|
4 months
|
|
Balance
Délai: 4 months
|
Balance was measured using the Modified Functional Reach Test
|
4 months
|
|
Quality of Life
Délai: 4 months
|
Quality of life was determined using the Short Form-36 (SF-36) Health Survey that contains 36 questions and produces scores for eight health related quality of life domains.
Each domain is transformed to a 0-100 scale.
Higher scores represents better health status while lower stores represents poor health status.
|
4 months
|
|
Lung Age
Délai: 4 months
|
Lung age was calculated based on FEV₁ values.
For male: Lung age (years)=(2.87×height in cm×0.394)-(31.25×FEV1 in L)-39.375
For females: Lung age (years)=(3.56×height in cm×0.394)-(40×FEV1 in L)-77.280
|
4 months
|
Collaborateurs et enquêteurs
Parrainer
Publications et liens utiles
Publications générales
- Morris JF, Temple W. Spirometric "lung age" estimation for motivating smoking cessation. Prev Med. 1985 Sep;14(5):655-62. doi: 10.1016/0091-7435(85)90085-4.
- Pinheiro L, Verhagen E, Ocarino J, Fagher K, Ahmed OH, Dalton K, Mann DL, Weiler R, Akinyi Okoth C, Blauwet CA, Lexell J, Derman W, Webborn N, Silva A, Resende R. Periodic health evaluation in Para athletes: a position statement based on expert consensus. BMJ Open Sport Exerc Med. 2024 Oct 9;10(4):e001946. doi: 10.1136/bmjsem-2024-001946. eCollection 2024.
- Freitas JP, Costa R, Barranco LC, Reis K, Lopes AJ, Mainenti MRM, Dos Santos Vigario P. Effect of inspiratory muscle training on pulmonary function, respiratory muscle strength, aerobic performance, sports skills, and quality of life in wheelchair rugby athletes. J Bodyw Mov Ther. 2024 Oct;40:360-365. doi: 10.1016/j.jbmt.2024.04.049. Epub 2024 Apr 20.
- Fischer G, Tarperi C, George K, Ardigo LP. An exploratory study of respiratory muscle endurance training in high lesion level paraplegic handbike athletes. Clin J Sport Med. 2014 Jan;24(1):69-75. doi: 10.1097/JSM.0000000000000003.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- Paralympic_Athlete
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .